BK has been paid for the time spent as a committee member for advisory boards (Brensocatib Advisory Board [BRAB] Insmed Incorporated, USA), other forms of consulting (Boehringer Ingelheim [Germany], Neuprozyme Therapeutics Aps [Denmark], Santhera Pharmaceuticals [Switzerland], Chiesi [Italy], Gerson Lehrman Group [GLG] [USA]), symposium organisation (Insmed Incorporated) and travel support, and lectures or presentations, outside of the submitted work
Non-GMO | Gluten-Free | Naturally Flavoured
Conforto e segurana para mdicos, enfermeiros e diabticos
48 GLP-1 RA injectable agents in development for obesity treatment Survodutide Studied in a phase 2 randomized, double-blind trial in persons with pre-obesity and obesity (without diabetes) for 46 weeks
10.1093/ajcn/nqz275 [DOI] [PMC free article] [PubMed] [Google Scholar] 160.Pasca L, Quaranta CA, Grumi S, Zanaboni MP, Tagliabue A, Guglielmetti M, et al